IHH Healthcare's Growth Momentum Likely to Be Sustained Into 2026 -- Market Talk

Dow Jones

14 hours ago

0104 GMT - IHH Healthcare's earnings momentum is expected to hold into 2026, Maybank IB analysts Nur Natasha Ariza and Yin Shao Yang say in a note. The outlook is supported by improving fundamentals in Turkey and Europe, patient recovery and operational efficiencies in India, steady demand and rising medical tourism in Malaysia, and utilization ramp-up in Singapore following the Mt. Elizabeth Orchard renovations. They raise IHH's 2025-2027 core net profit estimates by 5%, 1% and 2%, respectively, to factor in stronger revenue in Singapore and India. Maybank raises IHH's target price to MYR9.48 from MYR9.42 while maintaining a buy rating on the stock. Shares are unchanged at MYR8.07. (yingxian.wong@wsj.com)

(END) Dow Jones Newswires

November 26, 2025 20:04 ET (01:04 GMT)

At the request of the copyright holder, you need to log in to view this content

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/news/2586294602"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2586294602\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2586294602?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-11-27 09:04","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2586294602","market":"fut","top_or_hot":-1,"title":"IHH Healthcare's Growth Momentum Likely to Be Sustained Into 2026 -- Market Talk","media":"Dow Jones","content":"<font class=\"NormalMinus1\" face=\"Arial\">\n<p>\n     0104 GMT - IHH Healthcare's earnings momentum is expected to hold into 2026, Maybank IB analysts Nur Natasha Ariza and Yin Shao Yang say in a note. The outlook is supported by improving fundamentals in Turkey and Europe, patient recovery and operational efficiencies in India, steady demand and rising medical tourism in Malaysia, and utilization ramp-up in Singapore following the Mt. Elizabeth Orchard renovations. They raise IHH's 2025-2027 core net profit estimates by 5%, 1% and 2%, respectively, to factor in stronger revenue in Singapore and India. Maybank raises IHH's target price to MYR9.48 from MYR9.42 while maintaining a buy rating on the stock. Shares are unchanged at MYR8.07. (yingxian.wong@wsj.com) \n</p>\n<pre style=\"white-space: pre\">\n \n</pre>\n<p>\n  (END) Dow Jones Newswires\n</p>\n<p>\n  November 26, 2025 20:04 ET (01:04 GMT)\n</p>\n<p>\n  Copyright (c) 2025 Dow Jones &amp; Company, Inc.\n</p>\n</font>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>IHH Healthcare's Growth Momentum Likely to Be Sustained Into 2026 -- Market Talk</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nIHH Healthcare's Growth Momentum Likely to Be Sustained Into 2026 -- Market Talk\n</h2>\n\n<h4 class=\"meta\">\n\n\n<div class=\"head\" \">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Dow Jones </p>\n<p class=\"h-time\">2025-11-27 09:04</p>\n</div>\n\n</div>\n\n\n</h4>\n\n</header>\n<article>\n<font class=\"NormalMinus1\" face=\"Arial\">\n<p>\n     0104 GMT - IHH Healthcare's earnings momentum is expected to hold into 2026, Maybank IB analysts Nur Natasha Ariza and Yin Shao Yang say in a note. The outlook is supported by improving fundamentals in Turkey and Europe, patient recovery and operational efficiencies in India, steady demand and rising medical tourism in Malaysia, and utilization ramp-up in Singapore following the Mt. Elizabeth Orchard renovations. They raise IHH's 2025-2027 core net profit estimates by 5%, 1% and 2%, respectively, to factor in stronger revenue in Singapore and India. Maybank raises IHH's target price to MYR9.48 from MYR9.42 while maintaining a buy rating on the stock. Shares are unchanged at MYR8.07. (yingxian.wong@wsj.com) \n</p>\n<pre style=\"white-space: pre\">\n \n</pre>\n<p>\n  (END) Dow Jones Newswires\n</p>\n<p>\n  November 26, 2025 20:04 ET (01:04 GMT)\n</p>\n<p>\n  Copyright (c) 2025 Dow Jones &amp; Company, Inc.\n</p>\n</font>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK6092","symbol_name":"保健护理机构","start_time":0,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","article_id":"2586294602","we_media_id":"106","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2586294602","pubTimestamp":1764205440,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Dow Jones","introduction":"Dow Jones publishes the world’s most trusted business news and financial information in a variety of media.","home_visible":0,"id":"106","head_image":"https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99"},"summary":"0104 GMT - IHH Healthcare's earnings momentum is expected to hold into 2026, Maybank IB analysts Nur Natasha Ariza and Yin Shao Yang say in a note. The outlook is supported by improving fundamentals in Turkey and Europe, patient recovery and operational efficiencies in India, steady demand and rising medical tourism in Malaysia, and utilization ramp-up in Singapore following the Mt. Elizabeth Orchard renovations. They raise IHH's 2025-2027 core net profit estimates by 5%, 1% and 2%, respectively, to factor in stronger revenue in Singapore and India. Maybank raises IHH's target price to MYR9.48 from MYR9.42 while maintaining a buy rating on the stock. Shares are unchanged at MYR8.07. ","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK6092":"保健护理机构","BK6511":"医疗保健服务概念","BK4581":"高盛持仓","XLV":"健康照护类股ETF-SPDR","LABU":"三倍做多标普生物-Direxion","HCSG":"Healthcare Svcs Group Inc","XBI":"SPDR S&P Biotech ETF","LU0128526141.USD":"TEMPLETON GLOBAL SMALLER COMPANIES \"A\" ACC","BK4137":"综合支持服务","LU0029874061.USD":"TEMPLETON GLOBAL SMALLER COMPANIES \"A\" YDIS INC","BK4588":"碎股","Q0F.SI":"IHH医疗保健集团","BK4585":"ETF&股票定投概念"},"translate_title":"IHH Healthcare的增长势头可能会持续到2026年——市场讨论","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"HCSG":1.5,"Q0F.SI":0.9,"XLV":1.5,"LABU":0.6,"XBI":0.6,"MNDmain":0.76},"content_text":"0104 GMT - IHH Healthcare's earnings momentum is expected to hold into 2026, Maybank IB analysts Nur Natasha Ariza and Yin Shao Yang say in a note. The outlook is supported by improving fundamentals in Turkey and Europe, patient recovery and operational efficiencies in India, steady demand and rising medical tourism in Malaysia, and utilization ramp-up in Singapore following the Mt. Elizabeth Orchard renovations. They raise IHH's 2025-2027 core net profit estimates by 5%, 1% and 2%, respectively, to factor in stronger revenue in Singapore and India. Maybank raises IHH's target price to MYR9.48 from MYR9.42 while maintaining a buy rating on the stock. Shares are unchanged at MYR8.07. (yingxian.wong@wsj.com) \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  November 26, 2025 20:04 ET (01:04 GMT)\n\n\n  Copyright (c) 2025 Dow Jones & Company, Inc.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"dataReport","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":true,"code":"91000000","status":"200"}}}